20/20 GeneSystems, Inc.
https://2020gene.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From 20/20 GeneSystems, Inc.
New Products In Brief
Mela Sciences launches MelaFind melanoma detection device in the U.S. Medtronic launches CapSure Sense MRI SureScan pacing leads overseas. More product news.
Biomarker Diagnostics: Place Your Bets Wisely
Biomarker diagnostics are the linchpin of personalized medicine. But building a successful business around such tests is anything but straightforward, given the complexities associated with both their development and commercialization. Today's molecular diagnostic companies need to think carefully before they choose a "go it alone" strategy when developing a particular test. It may make more sense to forge a partnership with another diagnostic company or a drug developer with the goal of sharing costs and relative risks.
Clinical Update (10/2006)
Short summaries of notable clinical findings impacting the device industry: blood test may detect early-stage lung cancer; new device may help regrow teeth.
Company Information
- Industry
- Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Digital Health
- Artificial Intelligence
- Other Names / Subsidiaries
-
- 20/20 BioResponse
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice